Blinded evaluation of reverse transcriptase-polymerase chain reaction prostate-specific antigen peripheral blood assay for molecular staging of prostate cancer
- 1 April 1999
- Vol. 53 (4) , 714-721
- https://doi.org/10.1016/s0090-4295(98)00608-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- PROSTATE SPECIFIC ANTIGEN REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION ASSAY IN PREOPERATIVE STAGING OF PROSTATE CANCERJournal of Urology, 1997
- The use of RT-”nested" PCR of prostate specific antigen to detect hematogenous neoplastic cells in patients with prostate adenocarcinomaJournal of Molecular Medicine, 1997
- Positive prostate-specific antigen circulating cells detected by reverse transcriptasepolymerase chain reaction does not imply the presence of prostatic micrometastase sUrology, 1997
- Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinomaUrology, 1997
- Increased analytical sensitivity of RT-PCR of PSA mRNA decreases diagnostic specificity of detection of prostatic cells in bloodInternational Journal of Cancer, 1997
- Molecular staging of genitourinary malignanciesUrology, 1996
- Preoperative Reverse Transcriptase Polymerase Chain Reaction for Prostate Specific Antigen Predicts Treatment Failure Following Radical ProstatectomyJournal of Urology, 1996
- Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancerCancer, 1995
- Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assayUrology, 1994
- Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.Proceedings of the National Academy of Sciences, 1988